Huashan D. Shi
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: a single-arm phase II clinical trial.
Journal: Future oncology (London, England)
Published: July 14, 2026
First-in-human evidence of multidrug resistance reversal in solid tumors: a cohort analysis of carbon nanoparticles‑Fe(II) complex trials.
Journal: BMC cancer
Published: March 20, 2026
Glucocorticoid receptor activated by dexamethasone promotes the chemoresistance and stemness of lung cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 18, 2025
Personalized neoantigen DC vaccine combined with camrelizumab following definitive therapy in locally advanced unresectable esophageal squamous cell carcinoma (CHANT-241): protocol for a randomized controlled trial.
Journal: Frontiers in immunology
Published: July 03, 2025
Safety, Tolerability, and Pharmacokinetics of a Novel Nitroimidazooxazole Antitubercular Agent in Healthy Adults: A Phase I Trial.
Journal: MedComm
Published: July 01, 2025
Stromal-Derived IL-8 Promotes M2 Macrophage Polarization via the RhoA/MRTF-A/SRF Transcriptional Axis to Impair CD8+ T Cell Cytotoxicity in Lung Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 03, 2025
Thermosensitive hydrogel delivery of BCG lysates and tumor antigens: A novel strategy for melanoma immunoprevention and therapeutics.
Journal: Biochemical and biophysical research communications
Published: December 09, 2024
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.
Journal: Signal transduction and targeted therapy
Published: November 24, 2024
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages.
Journal: Signal transduction and targeted therapy
Published: November 21, 2024
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.
Journal: Nature biomedical engineering
Published: February 11, 2024
EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors.
Journal: Science advances
Published: December 01, 2023
Last Updated: 09/26/2026